Drug Profile


Alternative Names: NMSO3

Latest Information Update: 10 Oct 2012

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Fukushima Medical University; Nissin Food Products
  • Developer Fukushima Medical University; Microbiotix; Nissin Food Products; University of Texas Medical Branch
  • Class Antivirals; Lipids; Sulfates
  • Mechanism of Action CD4 antigen inhibitors; Virus attachment inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported HIV infections; Metapneumovirus infections; Rotavirus infections

Most Recent Events

  • 10 Oct 2012 No development reported - Preclinical for HIV infections in Japan (unspecified route)
  • 10 Oct 2012 No development reported - Preclinical for Metapneumovirus-infections in USA (Intranasal)
  • 10 Oct 2012 No development reported - Preclinical for Rotavirus infections in Japan (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top